Articles producció científica> Medicina i Cirurgia

Mcf-7 drug resistant cell lines switch their lipid metabolism to triple negative breast cancer signature

  • Dades identificatives

    Identificador: imarina:9242249
    Autors:
    Adria-Cebrian, JoseGuaita-Esteruelas, SandraLam, Eric W -FRodriguez-Balada, MartaCapellades, JordiGirona, JosefaJimenez-Santamaria, Ana MariaYanes, OscarMasana, LuisGuma, Josep
    Resum:
    Obesity and adipose tissue have been closely related to a poor cancer prognosis, especially in prostate and breast cancer patients. The ability of transferring lipids from the adipose tissue to the tumor cells is actively linked to tumor progression. However, different types of breast tumor seem to use these lipids in different ways and metabolize them in different pathways. In this study we have tracked by mass spectrometry how palmitic acid from the adipocytes is released to media being later incorporated in different breast cancer cell lines (MDA-MB-231, SKBR3, BT474, MCF-7 and its resistant MCF-7 EPIR and MCF-7 TAXR). We have observed that different lines metabolize the palmitic acid in a different way and use their carbons in the synthesis of different new lipid families. Furthermore, we have observed that the lipid synthesis pattern varied according to the cell line. Surprisingly, the metabolic pattern of the resistant cells was more related to the TNBC cell line compared to their sensitive cell line MCF-7. These results allow us to determine a specific lipid pattern in different cell lines that later might be used in breast cancer diagnosis and to find a better treatment according to the cancer molecular type. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
  • Altres:

    Autor segons l'article: Adria-Cebrian, Jose; Guaita-Esteruelas, Sandra; Lam, Eric W -F; Rodriguez-Balada, Marta; Capellades, Jordi; Girona, Josefa; Jimenez-Santamaria, Ana Maria; Yanes, Oscar; Masana, Luis; Guma, Josep
    Departament: Enginyeria Electrònica, Elèctrica i Automàtica Medicina i Cirurgia Ciències Mèdiques Bàsiques
    Autor/s de la URV: Adriá Cebrián, Jose / Girona Tell, Josefa / GUAITA ESTERUELAS, SANDRA / Gumà Padró, José / Masana Marín, Luis / RODRÍGUEZ BALADA, MARTA / Yanes Torrado, Óscar
    Paraules clau: Tumor-surrounding adipocytes Tumor microenvironment Mass spectrometry Lipids Fabp5 Fabp4 Cd36 Breast Adipocytes tumor microenvironment sphingolipids progression mass spectrometry lipids fabp5 fabp4 cd36 adipocytes
    Resum: Obesity and adipose tissue have been closely related to a poor cancer prognosis, especially in prostate and breast cancer patients. The ability of transferring lipids from the adipose tissue to the tumor cells is actively linked to tumor progression. However, different types of breast tumor seem to use these lipids in different ways and metabolize them in different pathways. In this study we have tracked by mass spectrometry how palmitic acid from the adipocytes is released to media being later incorporated in different breast cancer cell lines (MDA-MB-231, SKBR3, BT474, MCF-7 and its resistant MCF-7 EPIR and MCF-7 TAXR). We have observed that different lines metabolize the palmitic acid in a different way and use their carbons in the synthesis of different new lipid families. Furthermore, we have observed that the lipid synthesis pattern varied according to the cell line. Surprisingly, the metabolic pattern of the resistant cells was more related to the TNBC cell line compared to their sensitive cell line MCF-7. These results allow us to determine a specific lipid pattern in different cell lines that later might be used in breast cancer diagnosis and to find a better treatment according to the cancer molecular type. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
    Àrees temàtiques: Oncology Medicina iii Cancer research
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: josefa.girona@urv.cat oscar.yanes@urv.cat jose.adria@estudiants.urv.cat josefa.girona@urv.cat jose.guma@urv.cat luis.masana@urv.cat
    Identificador de l'autor: 0000-0002-6267-8779 0000-0003-3695-7157 0000-0002-6267-8779 0000-0001-7541-9832 0000-0002-0789-4954
    Data d'alta del registre: 2024-10-12
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://www.mdpi.com/2072-6694/13/
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Cancers. 13 (23): 5871-
    Referència de l'ítem segons les normes APA: Adria-Cebrian, Jose; Guaita-Esteruelas, Sandra; Lam, Eric W -F; Rodriguez-Balada, Marta; Capellades, Jordi; Girona, Josefa; Jimenez-Santamaria, Ana Ma (2021). Mcf-7 drug resistant cell lines switch their lipid metabolism to triple negative breast cancer signature. Cancers, 13(23), 5871-. DOI: 10.3390/cancers13235871
    DOI de l'article: 10.3390/cancers13235871
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2021
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Cancer Research,Oncology
    Tumor-surrounding adipocytes
    Tumor microenvironment
    Mass spectrometry
    Lipids
    Fabp5
    Fabp4
    Cd36
    Breast
    Adipocytes
    tumor microenvironment
    sphingolipids
    progression
    mass spectrometry
    lipids
    fabp5
    fabp4
    cd36
    adipocytes
    Oncology
    Medicina iii
    Cancer research
  • Documents:

  • Cerca a google

    Search to google scholar